Log in Join free

Open access

Interleukin-15-armored ALPPL2 CAR T cells demonstrate robust preclinical efficacy for solid tumors

Junquan Liu Ning-Yan Zhang Zhi-Qiang An A. Heczey

Aug 2026 · Molecular therapy. Oncology · Vol 34 · 0 citations · 9 references

Medicine

Abstract

Chimeric antigen receptor (CAR) T therapy

DOI PubMed Semantic Scholar

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.